Posizioni attive di Steven Fang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Invitrocue Pte Ltd.
 Invitrocue Pte Ltd. BiotechnologyHealth Technology Invitrocue Pte Ltd. provides products and services in the fields of in vitro drug metabolism and pharmacokinetics (DMPK), in vitro toxicology, and digital pathology utilizing cell-based models and image analytics. It also offers realms of drug testing and research and development of cosmeceuticals and medical devices solutions. The firm’s technology also provides cuepath platform, web-based platform, view share, manage, and analyze virtual slides and information. The company was founded by Steven Fang in 2012 and is headquartered in Singapore. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | - | - | |
| Fondatore | - | - |
Storia della carriera di Steven Fang
Precedenti posizioni note di Steven Fang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INVITROCUE LIMITED | Direttore/Membro del Consiglio | 01/01/2012 | - |
| Fondatore | 01/01/2012 | - |
Statistiche
Distribuzione geografica
| Australia | 2 |
| Singapore | 2 |
Posizioni
| Director/Board Member | 2 |
| Founder | 2 |
| Chief Executive Officer | 1 |
Settori
| Health Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Invitrocue Ltd.
 Invitrocue Ltd. Medical/Nursing ServicesHealth Services Invitrocue Ltd. engages in the provision of bio analytic solutions including in vitro cell-based testing technologies and image analytics software for use in digital pathology. The firm focuses on the commercialization of its bio analytics services using cell based model and imaging based technology. The company was founded by Steven Fang Boon Sing and Hanry Yu in 2012 and is headquartered in Sydney, Australia. | Health Services |
Invitrocue Pte Ltd.
Invitrocue Pte Ltd. BiotechnologyHealth Technology Invitrocue Pte Ltd. provides products and services in the fields of in vitro drug metabolism and pharmacokinetics (DMPK), in vitro toxicology, and digital pathology utilizing cell-based models and image analytics. It also offers realms of drug testing and research and development of cosmeceuticals and medical devices solutions. The firm’s technology also provides cuepath platform, web-based platform, view share, manage, and analyze virtual slides and information. The company was founded by Steven Fang in 2012 and is headquartered in Singapore. | Health Technology |
- Borsa valori
- Insiders
- Steven Fang
- Esperienza
